Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation
Crossref DOI link: https://doi.org/10.1007/s10840-016-0195-5
Published Online: 2016-10-22
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ukaigwe, Anene
Shrestha, Pragya
Karmacharya, Paras
Hussain, Sarah K.
Samii, Soraya
Gonzalez, Mario D.
Wolbrette, Deborah
Naccarrelli, Gerald V.
License valid from 2016-10-22